Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk by Farsang C

Get full text

2018 ESC/ESH guidelines for themanagement of arterial hypertension by Williams, B, Mancia, G, Spiering, W, Rosei, EA, Azizi, M, Burnier, M, Clement, DL, Coca, A, De Simone, G, Dominiczak, A, Kahan, T, Mahfoud, F, Redon, J, Ruilope, L, Zanchetti, A, Kerins, M, Kjeldsen, SE, Kreutz, R, Laurent, S, Lip, GYH, McManus, R, Narkiewicz, K, Ruschitzka, F, Schmieder, RE, Shlyakhto, E, Tsioufis, C, Aboyans, V, Desormais, I, De Backer, G, Heagerty, AM, Agewall, S, Bochud, M, Borghi, C, Boutouyrie, P, Brguljan, J, Bueno, H, Caiani, EG, Carlberg, B, Chapman, N, Cífková, R, Cleland, JGF, Collet, JP, Coman, IM, De Leeuw, PW, Delgado, V, Dendale, P, Diener, HC, Dorobantu, M, Fagard, R, Farsang, C, Ferrini, M, Graham, IM, Grassi, G, Haller, H, Hobbs, FDR, Jelakovic, B, Jennings, C, Katus, HA, Kroon, AA, Leclercq, C, Lovic, D, Lurbe, E, Manolis, AJ, McDonagh, TA, Messerli, F, Muiesan, ML, Nixdorff, U, Olsen, MH, Parati, G, Perk, J, Piepoli, MF, Polonia, J, Ponikowski, P, Richter, DJ, Rimoldi, SF, Roffi, M, Sattar, N, Seferovic, PM, Simpson, IA, Sousa-Uva, M, Stanton, AV, Van De Borne, P, Vardas, P, Volpe, M, Wassmann, S, Windecker, S, Zamorano, JL